TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • What Our Clients Say About Us
    • Corporate Social Responsibility
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access Strategy
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Artificial Intelligence and Data Science
            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services

          • Regulatory Affairs

            • Clinical Trial Applications (CTA)
            • Global Procedure Management
            • Health Authority / Agency Interaction

          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting

          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Scientific, Regulatory and Technical Writing
            • Statistical Services

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
            • Risk Management Support

          • Quality

            • Commercialization Readiness
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
            • Validation
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Toxicology Services

          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management

          • Quality

            • Commissioning and Qualification
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Systems
            • Validation
            • Vendor Audit
            • Vendor Management and Oversight

          • Medical Affairs

            • Medical Information
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medical Device Services
            • Medicinal Products
            • Pharmaceutical
            • Veterinary Drugs

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacoepidemiology
            • Statistical Services
            • Supporting Rx to OTC switches
            • Technology Enabled Services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > News & Events > News

News

EFPIA Publishes Survey Results on Brexit Amid Calls for Maximum Regulatory Alignment

EFPIA Publishes Survey Results on Brexit Amid Calls for Maximum Regulatory Alignment

14th November 2017

PharmaLex strengthens international executive team

PharmaLex strengthens international executive team

11th November 2017

PharmaLex Group collaborates with Kiana Systems

PharmaLex Group collaborates with Kiana Systems

9th November 2017

PharmaLex Group enters into strategic partnership with Volv Global SA

PharmaLex Group enters into strategic partnership with Volv Global SA

5th November 2017

PharmaLex France approved for the Research Tax Credit

PharmaLex France approved for the Research Tax Credit

5th September 2017

Judith K. Jones, MD, PhD honored by ISPE

Judith K. Jones, MD, PhD honored by ISPE

4th September 2017

PharmaLex Group further strengthens quality management and compliance services

PharmaLex Group further strengthens quality management and compliance services

28th August 2017

PharmaLex Group further strengthens senior regulatory expertise

PharmaLex Group further strengthens senior regulatory expertise

16th August 2017

Interview with David Jefferys on “Brexit – possible implications”

Interview with David Jefferys on “Brexit – possible implications”

31st July 2017

CO.DON AG achieves remarkable outcome, receiving EU marketing authorization for Spherox

CO.DON AG achieves remarkable outcome, receiving EU marketing authorization for Spherox

14th July 2017

PharmaLex Group strengthens biosimilar expertise

PharmaLex Group strengthens biosimilar expertise

10th July 2017

PharmaLex Group expands service provision with the addition of health economics in the Nordics

PharmaLex Group expands service provision with the addition of health economics in the Nordics

4th July 2017
1
2345678910111213141516
…1718192021
prevnext
Upcoming Webinars

November 17th, 2020

AQbD – Analytical Quality by Design

3PM CEST

November 18th, 2020

Bayesian Adaptive Approaches in Rare and Pediatric Disease

4:00 PM CEST

December 8th, 2020

Applied AI for Pharmaceutical R&D

Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.

    Top 10 Pharma Company
    President
PharmaLex
©2020 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





Select your state:

.
You can unsubscribe at any time at data.protection@pharmalex.com

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.





Select your state:

.
You can unsubscribe at any time at data.protection@pharmalex.com

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

Privacy Policy

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.